Characterization of MYC dependence in human breast cancer cells. (A)... | Download Scientific Diagram
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
MYC promotes cancer progression by modulating m6A modifications to suppress target gene translation | EMBO reports
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer | PNAS
Frontiers | Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells
IJMS | Free Full-Text | High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
Targeting MYC to Combat Pancreatic Cancer
MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria - Motaparthi - 2021 - Journal
XL MYC amp - Amplification Probe | MetaSystems Probes
MYC dysfunction modulates stemness and tumorigenesis in breast cancer
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses | British Journal of Cancer
MYC dysfunction modulates stemness and tumorigenesis in breast cancer
Frontiers | Molecular Mechanisms of MYCN Dysregulation in Cancers
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value - ScienceDirect
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas: Cell Systems
Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat | Signal Transduction and Targeted Therapy
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 | eLife
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors | Modern Pathology
Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers | PLOS ONE
MYC amplification in breast cancer: a chromogenic in situ hybridisation study | Journal of Clinical Pathology
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers | Breast Cancer Research | Full Text
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer - eBioMedicine
